8/19/2005 Pavad Medical Inc., which is developing an implantable device to treat obstructive sleep apnea, closed a $7.5 million Series B round last week, Canaan Partners General Partner Brent Ahrens told VentureWire.
8/19/2005 Pavad Medical Inc., which is developing an implantable device to treat obstructive sleep apnea, closed a $7.5 million Series B round last week, Canaan Partners General Partner Brent Ahrens told VentureWire.
